Rubius Therapeutics Inc
RUBY
Morningstar Rating
Skip to Content
Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress
Rubius Therapeutics to Participate in Jefferies London Healthcare Conference
Rubius Therapeutics Appoints Maiken Keson-Brookes as Chief Legal Officer and Corporate Secretary
Rubius Therapeutics Highlights Preclinical Oncology Data at Society for Immunotherapy of Cancer Annual Meeting and AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Rubius Therapeutics to Announce Third Quarter 2019 Financial Results
Entrada Therapeutics Appoints Nathan Dowden as Chief Operating Officer
Rubius Therapeutics Announces Oncology Poster Presentations at Upcoming Medical Conferences